• $100

Generic Peptides

In addition, CPC specializes in the production of generic peptides on an industrial scale, following the CGMP’s (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards.    

 

Our Generic API Portfolio:

 Disease Area

API

Indication

DMF Status

Tumour

Leuprorelin Acetate

Prostate & Breast Cancer; 

Endometriosis; Uterine Leiomyomata; 

Precocious Puberty

MFDS: 20200625-210-J-661              

NMPA: Y20190007496(A)

TFDA: 110DMF050097

Triptorelin Acetate

Prostate & Breast Cancer; 

Endometriosis; Uterine Leiomyomata; 

Assisted Reproduction

NMPA: Y20170001090(A)

Goserelin Acetate

Suppress production of the sex hormones

NMPA: Y20230000413

Triptorelin Pamoate

Endometriosis; Uterine Fibroids; 

Premature Puberty; Prostate Cancer; ART.

NMPA:2024 Q2

Procreation

Cetrorelix Acetate

In Vitro Fertilization (IVF)

NMPA: Y20190001147(A)FDA: 034884

Diabetes

Exenatide Acetate

Exenatide is an injectable diabetes medicine 

that helps control blood sugar levels. 

This medication helps pancreas produce 

insulin more efficiently

NMPA: 2015/12                           

NMPA: Y20170001378

Semaglutide

Type ll diabetes

DMF: 2024 Q1

NMPA: 2024 Q1

Tirzepatide

Type ll diabetes

Early R&D

Gastrointetinal

Terlipressin Acetate

An analogue of vasopressin, prescribed for 

bleeding esophageal varices, septic shock, 

hepatorenal syndrome and in management of 

low blood pressure

NMPA:Y20200000281(A)

CEP : 2020-111 

ASMF: The Nethelands (03883)

ASMF: Germany (4388)

EDQM: R0-CEP 2020-111

Linaclotide

lrritable Bowel Syndrome with Constipation (IBS-C):

Chronic Idiopathic Constipation (CIC)

NMPA:Y20210000906

Teduglutide

A prescription medicine for adults with Short Bowel Syndrome 

who need additional nutrition or fluids fromIV feeding

DMF:2024 Q4

Immunoloy

Difelikefalin

Treatment of moderate-to-severe pruritus associated with 

chronic kidney disease(CKD-aP; uremic pruritus) 

in adults undergoing hemodialysis

 NMPA:2025 Q1